Picture of Sun Pharma Advanced Research logo

SPARC — Sun Pharma Advanced Research News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Sun Pharma Advanced Research Says USFDA Accepted Co's NDA For Taclantis

July 1 (Reuters) - Sun Pharma Advanced Research Company Ltd
 SPRC.NS :
    * USFDA ACCEPTED FOR REVIEW SPARC’S NEW DRUG APPLICATION FOR
TACLANTIS

Source text: http://bit.ly/2KPZxjY
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharma Advanced Research

See all news